Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5614 USD | +7.26% | +1.01% | +3.33% |
May. 09 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 | MT |
Financials (USD)
Sales 2024 * | 38.65M | Sales 2025 * | 69.73M | Capitalization | 116M |
---|---|---|---|---|---|
Net income 2024 * | -110M | Net income 2025 * | -65M | EV / Sales 2024 * | 4.07 x |
Net Debt 2024 * | 40.79M | Net Debt 2025 * | 129M | EV / Sales 2025 * | 3.52 x |
P/E ratio 2024 * |
-1.03
x | P/E ratio 2025 * |
-2.04
x | Employees | 405 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.28% |
Latest transcript on Sangamo Therapeutics, Inc.
1 day | +7.26% | ||
1 week | +1.01% | ||
Current month | +9.03% | ||
1 month | +7.14% | ||
3 months | -2.26% | ||
6 months | +88.96% | ||
Current year | +3.33% |
Managers | Title | Age | Since |
---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 61 | 16-05-31 |
Director of Finance/CFO | 46 | 19-02-28 | |
Gregory Davis
CTO | Chief Tech/Sci/R&D Officer | - | 20-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peg Horn
BRD | Director/Board Member | 61 | 22-12-14 |
James Meyers
BRD | Director/Board Member | 59 | 19-11-21 |
H. Parker
CHM | Chairman | 68 | 14-06-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.66% | 2 M€ | -25.75% | ||
0.49% | 0 M€ | -4.02% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.5614 | +7.26% | 4,769,970 |
24-05-09 | 0.5234 | +4.18% | 2,280,030 |
24-05-08 | 0.5024 | -6.95% | 1,572,874 |
24-05-07 | 0.5399 | +2.55% | 1,660,592 |
24-05-06 | 0.5265 | -5.27% | 865,396 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.33% | 116M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- SGMO Stock